Private Trust Company’s BeOne Medicines Ltd ONC Stock Holding History

Private Trust Company’s Portfolio ONC Stock Details ONC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$4.56K	Buy	16 +7	+78%	+$2.06K	﹤0.01%	2314
2026 Q1	$2.67K	Hold	9	–	–	﹤0.01%	2342
2025 Q4	$2.73K	Hold	9	–	–	﹤0.01%	2307
2025 Q3	$3.07K	Hold	9	–	–	﹤0.01%	2272
2025 Q2	$2.18K	Hold	9	–	–	﹤0.01%	2251
2025 Q1	$2.45K	Sell	9 -1	-10%	-$234	﹤0.01%	2223
2024 Q4	$1.85K	Sell	10 -43	-81%	-$8.79K	﹤0.01%	2180
2024 Q3	$11.9K	Sell	53 -9	-15%	-$1.62K	﹤0.01%	1658
2024 Q2	$8.85K	Buy	62 +1	+2%	+$154	﹤0.01%	1724
2024 Q1	$9.54K	Buy	61 +8	+15%	+$1.29K	﹤0.01%	1677
2023 Q4	$9.56K	Hold	53	–	–	﹤0.01%	1669
2023 Q3	$9.53K	Sell	53 -2	-4%	-$396	﹤0.01%	1616
2023 Q2	$9.81K	Sell	55 -16	-23%	-$3.69K	﹤0.01%	1633
2023 Q1	$15.3K	Sell	71 -1	-1%	-$240	﹤0.01%	1432
2022 Q4	$16K	Buy	72 +13	+22%	+$2.38K	﹤0.01%	1391
2022 Q3	$8K	Sell	59 -21	-26%	-$3.61K	﹤0.01%	1550
2022 Q2	$13K	Buy	+80	New	+$12.5K	﹤0.01%	1404

Other funds holding ONC

BBA

Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return

Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return

Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

Citadel Advisors Miami, Florida $875B AUM 40.91% 1-Year Est. Return

Temasek Holdings Singapore $37.3B AUM 12.6% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

Private Trust Company's ONC Position: Q2 2026 in Review

Private Trust Company increased its BeOne Medicines Ltd (ONC) stake by 78% in Q2 2026, buying an estimated $2.06K and bringing the position to 16 shares worth $4.56K. The position accounts for ﹤0.01% of the portfolio, ranked #2314.

Private Trust Company first reported a position in ONC in Q2 2022 and has held it in 17 quarters since. The position peaked at $16K in Q4 2022. 282 funds tracked by Wall St. Rank hold ONC as of Q2 2026.

Private Trust Company held 16 shares of BeOne Medicines Ltd worth $4.56K as of Q2 2026.
Private Trust Company bought 7 BeOne Medicines Ltd shares in Q2 2026, an estimated $2.06K.
BeOne Medicines Ltd made up ﹤0.01% of Private Trust Company's portfolio in Q2 2026, its #2314 holding.
Private Trust Company first reported a position in BeOne Medicines Ltd in Q2 2022 and has held it in 17 quarters since.
Private Trust Company's BeOne Medicines Ltd position peaked at $16K in Q4 2022.
282 funds tracked by Wall St. Rank held BeOne Medicines Ltd as of Q2 2026.

Based on Private Trust Company's 13F filing for Q2 2026, filed 28 Jul 2026.